Vera Therapeutics, Inc.
VERACIK 0001831828 · Every Form 4 filed by insiders at this issuer.
Filings
9
Latest Mar 25, 2024
Unique insiders
7
Showing
9 of 9
Page 1
Top insiders
Most active reporters at Vera Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Fordyce Marshall | OfficerDirector | 2 |
| Katabi Maha | Director | 2 |
| Brenner Robert | Officer | 1 |
| COMMODORE CAPITAL LP | 10% Owner | 1 |
| Grant Sean | Officer | 1 |
| Turner William D. | Officer | 1 |
| Young Joseph R | Officer | 1 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 25, 2024 | Katabi Maha Director | S | 413,450 | $40.51 | $16,748,860 | |
| Feb 1, 2024 | Katabi Maha Director | P | 161,290 | $31.00 | $4,999,990 | |
| Jan 18, 2024 | Grant Sean CHIEF FINANCIAL OFFICER | A | 26,250 | $0.00 | $0 | |
| Jan 18, 2024 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | A | 21,875 | $0.00 | $0 | |
| Jan 18, 2024 | Fordyce Marshall PRESIDENT AND CEO · Director | A | 78,750 | $0.00 | $0 | |
| Jan 12, 2024 | COMMODORE CAPITAL LP 10% Owner | S | 1,050,000 | $18.00 | $18,900,000 | |
| Jan 9, 2024 | Turner William D. Chief Development Officer | Holdings only | — | — | — | |
| Jan 8, 2024 | Brenner Robert Chief Medical Officer | Holdings only | — | — | — | |
| Jan 3, 2024 | Fordyce Marshall President and CEO · Director | M | 13,000 | $2.8968 | $37,658 |
Showing 1–9 of 9
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.